Purinergic Signaling, HIF, and ROS Interactions in Myocardial I/R Injury: Therapeutic Potential and Future...

Area of Science:

• Cardiovascular Research
• Inflammation and Immunology
• Molecular Medicine

Background:

• Purinergic signaling is crucial in inflammatory diseases and cardiovascular events.
• Myocardial infarction (MI) triggers a cascade of hypoxia, inflammation, and oxidative stress, leading to cardiomyocyte death.
• Myocardial ischemic/reperfusion injury (MIRI) is a significant complication of restoring blood flow after MI.

Purpose of the Study:

• To review the mechanistic "triad axis" (adenosine signaling, HIF stabilization, ROS homeostasis) governing cardiomyocyte death in MIRI.
• To examine cell-specific roles of adenosine signaling in immune responses during ischemia.
• To highlight potential chronotherapeutic strategies targeting mitochondrial ROS and HIF signaling for ischemic heart disease (IHD).

Main Methods:

• Literature review focusing on purinergic signaling, MIRI, and related pathways.
• Analysis of mechanistic links between adenosine, hypoxia-inducible factor (HIF), and reactive oxygen species (ROS).
• Exploration of cell-specific immune modulation by adenosine signaling.

Main Results:

• The "triad axis" of adenosine, HIF, and ROS is a critical determinant of cardiomyocyte death in MIRI.
• Adenosine signaling influences immune cell infiltration and function in the ischemic heart.
• Mitochondrial ROS and HIF signaling show links to circadian rhythms, suggesting chronotherapeutic potential.

Conclusions:

• Understanding the interplay of adenosine, HIF, and ROS is vital for MIRI pathophysiology.
• Targeting these pathways, potentially with chronotherapy, offers new avenues for treating ischemic heart disease.
• Cell-specific effects of adenosine signaling on immune cells warrant further investigation in MIRI.